Kiora Pharmaceuticals Inc
Pharmaceutical company · Encinitas, California, United States · Nasdaq: KPRX
Kiora Pharmaceuticals Inc is a pharmaceutical company headquartered in Encinitas, California, United States. Its earliest recorded incorporation is in 2004. Its shares trade on Nasdaq under the ticker KPRX. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2026.
Kiora Pharmaceuticals at a glance
What does Kiora Pharmaceuticals do?
Private fundraising reported to the SEC
17 Form D notices; the most recent reported $5 million sold (2026).
Frequently asked questions about Kiora Pharmaceuticals
Where is Kiora Pharmaceuticals headquartered?
Kiora Pharmaceuticals Inc is headquartered in Encinitas, California, United States.
What does Kiora Pharmaceuticals do?
Kiora Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Kiora Pharmaceuticals a public company?
Yes. Kiora Pharmaceuticals Inc trades on Nasdaq under the ticker KPRX.
When was Kiora Pharmaceuticals founded?
The earliest incorporation on record for Kiora Pharmaceuticals Inc is in 2004, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.